Primary Target Audience:

Pulmonary, Allergy, Sleep and Critical Care faculty and staff, medicine faculty, trainees in medicine, allergy, pulmonary and critical care, and BU community members with an interest in pulmonary, allergy, sleep and critical care medicine.

Overall Objective:

-Explain why sedatives are administered to mechanically ventilated patients, and the simultaneous potential risks associated with this practice
-Describe how validated scoring systems related to depth of sedation (e.g. RASS) are used in the administration of sedative medications in the intensive care unit
-Identify the wide variation in sedation practices across United States ICUs as related to depth of sedation of mechanically ventilated patients, and identify factors associated with this variation

Faculty/Planning Committee:
Katrina E Traber, MD, Course Director, has no relevant financial relationships to disclose.

Justin Kwan Lui, MD, Planning Committee, has no relevant financial relationships to disclose.

Kathy Adamson, Activity Admin, has no relevant financial relationships to disclose.
Sakina Flint, Program Manager, Continuing Medical Education, has no relevant financial relationships to disclose.

Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

Disclosure Policy:
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer:

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Session date: 
01/26/2022 - 4:00pm to 4:30pm EST
  • 0.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.50 Participation

Please login or register to take this course.